Peanut allergies can be a serious and life-threatening condition that affects millions of people worldwide. For those who have a peanut allergy, exposure to peanuts — even in trace amounts — can ...
A landmark trial has found that low-dose peanut oral immunotherapy safely desensitised more than 82% of preschool children ...
By Dennis Thompson HealthDay ReporterFRIDAY, May 8, 2026 (HealthDay News) — Exposure therapy can successfully protect ...
Living with a peanut allergy means navigating a world where a single bite could turn deadly. For the estimated 1.2 million Americans who face this reality daily, understanding how to respond when ...
About 17 million people in the U.S. have an IgE-mediated food allergy, a condition where the immune system overreacts to ...
A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...
A new Lancet study found low-dose peanut immunotherapy safely desensitised 82 per cent of allergic preschool children, ...
Researchers at Karolinska Institutet have successfully treated children aged 1–3 years with peanut allergies. The children ...
Peanut allergy oral immunotherapy in toddlers shows that peanut puff desensitisation may safely help children aged 1–3 build ...
Mondelēz Global LLC, a subsidiary of snack foods giant Mondelez International (Nasdaq: MDLZ), which owns brands including Cadbury, Chips Ahoy!, Honey Maid, Oreo, Sour Patch Kids, and Toblerone, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results